Moleculin Biotech, Inc. Made Headway

Fri, Feb 14, 2025 at 07:31 PM
Moleculin Biotech, Inc. Made Headway

Moleculin Biotech, Inc. (MBRX:NASDAQ) rocketted at $2.18, a gain of 71.7%. On Fri, Feb 14, 2025, MBRX:NASDAQ touched a New 2-Week High of $2.18. The stock appeared on our News Catalysts scanner on Fri, Feb 14, 2025 at 11:36 AM in the 'EARNINGS' category. From Fri, Jan 31, 2025, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Thu, Feb 13, 2025 at $3.65 with a volume of 100M+.

About Moleculin Biotech, Inc. (MBRX:NASDAQ)

Moleculin Biotech Inc is a preclinical stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.